Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 96

1.

TNFα antagonization alters NOS2 dependent nasopharyngeal carcinoma tumor growth.

Bourouba M, Zergoun AA, Maffei JS, Chila D, Djennaoui D, Asselah F, Amir-Tidadini ZC, Touil-Boukoffa C, Zaman MH.

Cytokine. 2015 Jul;74(1):157-63. doi: 10.1016/j.cyto.2015.04.003. Epub 2015 Apr 23.

PMID:
25912222
2.

IL-6/NOS2 inflammatory signals regulate MMP-9 and MMP-2 activity and disease outcome in nasopharyngeal carcinoma patients.

Zergoun AA, Zebboudj A, Sellam SL, Kariche N, Djennaoui D, Ouraghi S, Kerboua E, Amir-Tidadini ZC, Chilla D, Asselah F, Touil-Boukoffa C, Merghoub T, Bourouba M.

Tumour Biol. 2016 Mar;37(3):3505-14. doi: 10.1007/s13277-015-4186-4. Epub 2015 Oct 9.

3.

Epigenetic inactivation of follistatin-like 1 mediates tumor immune evasion in nasopharyngeal carcinoma.

Zhou X, Xiao X, Huang T, Du C, Wang S, Mo Y, Ma N, Murata M, Li B, Wen W, Huang G, Zeng X, Zhang Z.

Oncotarget. 2016 Mar 29;7(13):16433-44. doi: 10.18632/oncotarget.7654.

4.

Pectolinarigenin Suppresses the Tumor Growth in Nasopharyngeal Carcinoma.

Wang C, Cheng Y, Liu H, Xu Y, Peng H, Lang J, Liao J, Liu H, Liu H, Fan J.

Cell Physiol Biochem. 2016;39(5):1795-1803. Epub 2016 Oct 17.

5.

LPLUNC1 suppresses IL-6-induced nasopharyngeal carcinoma cell proliferation via inhibiting the Stat3 activation.

Liao Q, Zeng Z, Guo X, Li X, Wei F, Zhang W, Li X, Chen P, Liang F, Xiang B, Ma J, Wu M, Tang H, Deng M, Zeng X, Tang K, Xiong W, Li G.

Oncogene. 2014 Apr 17;33(16):2098-109. doi: 10.1038/onc.2013.161. Epub 2013 May 27.

PMID:
23708661
6.

Berberine suppresses tumorigenicity and growth of nasopharyngeal carcinoma cells by inhibiting STAT3 activation induced by tumor associated fibroblasts.

Tsang CM, Cheung YC, Lui VW, Yip YL, Zhang G, Lin VW, Cheung KC, Feng Y, Tsao SW.

BMC Cancer. 2013 Dec 31;13:619. doi: 10.1186/1471-2407-13-619.

7.

Monocyte-derived factors including PLA2G7 induced by macrophage-nasopharyngeal carcinoma cell interaction promote tumor cell invasiveness.

Low HB, Png CW, Li C, Wang Y, Wong SB, Zhang Y.

Oncotarget. 2016 Aug 23;7(34):55473-55490. doi: 10.18632/oncotarget.10980.

8.

Over-expression of the special AT rich sequence binding protein 1 (SATB1) promotes the progression of nasopharyngeal carcinoma: association with EBV LMP-1 expression.

Shen Z, Zeng Y, Guo J, Wu Y, Jiang X, Ding R, Wu C, Li R, Luo B, Zeng C, Jiang H, Jie W.

J Transl Med. 2013 Sep 18;11:217. doi: 10.1186/1479-5876-11-217.

9.

Reduction of NOS2 overexpression in rheumatoid arthritis patients treated with anti-tumor necrosis factor alpha monoclonal antibody (cA2).

Perkins DJ, St Clair EW, Misukonis MA, Weinberg JB.

Arthritis Rheum. 1998 Dec;41(12):2205-10.

PMID:
9870877
10.

Epstein-Barr Virus-Induced VEGF and GM-CSF Drive Nasopharyngeal Carcinoma Metastasis via Recruitment and Activation of Macrophages.

Huang D, Song SJ, Wu ZZ, Wu W, Cui XY, Chen JN, Zeng MS, Su SC.

Cancer Res. 2017 Jul 1;77(13):3591-3604. doi: 10.1158/0008-5472.CAN-16-2706. Epub 2017 May 8.

11.

EBV-encoded RNA via TLR3 induces inflammation in nasopharyngeal carcinoma.

Li Z, Duan Y, Cheng S, Chen Y, Hu Y, Zhang L, He J, Liao Q, Yang L, Sun LQ.

Oncotarget. 2015 Sep 15;6(27):24291-303.

12.

KAI1 overexpression promotes apoptosis and inhibits proliferation, cell cycle, migration, and invasion in nasopharyngeal carcinoma cells.

Guo Z, Wang Y, Yang J, Zhong J, Liu X, Xu M.

Am J Otolaryngol. 2017 Sep - Oct;38(5):511-517. doi: 10.1016/j.amjoto.2016.09.011. Epub 2016 Sep 28.

PMID:
28583320
13.

Higher IGFBP-1 to IGF-1 serum ratio predicts unfavourable survival in patients with nasopharyngeal carcinoma.

Feng X, Lin J, Xing S, Liu W, Zhang G.

BMC Cancer. 2017 Jan 31;17(1):90. doi: 10.1186/s12885-017-3068-0.

14.

UBE2T promotes nasopharyngeal carcinoma cell proliferation, invasion, and metastasis by activating the AKT/GSK3β/β-catenin pathway.

Hu W, Xiao L, Cao C, Hua S, Wu D.

Oncotarget. 2016 Mar 22;7(12):15161-72. doi: 10.18632/oncotarget.7805.

15.

A novel Hsp90 inhibitor AT13387 induces senescence in EBV-positive nasopharyngeal carcinoma cells and suppresses tumor formation.

Chan KC, Ting CM, Chan PS, Lo MC, Lo KW, Curry JE, Smyth T, Lee AW, Ng WT, Tsao GS, Wong RN, Lung ML, Mak NK.

Mol Cancer. 2013 Oct 24;12(1):128. doi: 10.1186/1476-4598-12-128.

16.

Met degradation by SAIT301, a Met monoclonal antibody, reduces the invasion and migration of nasopharyngeal cancer cells via inhibition of EGR-1 expression.

Lee BS, Kang S, Kim KA, Song YJ, Cheong KH, Cha HY, Kim CH.

Cell Death Dis. 2014 Apr 10;5:e1159. doi: 10.1038/cddis.2014.119.

17.

Polymorphisms in oxidative stress-related genes are associated with nasopharyngeal carcinoma susceptibility.

Ben Chaaben A, Mariaselvam C, Salah S, Busson M, Dulphy N, Douik H, Ghanem A, Boukaouci W, Al Daccak R, Mamoghli T, Harzallah L, Bouassida J, Fortier C, Gritli S, Ben Hamida J, Charron D, Krishnamoorthy R, Guemira F, Tamouza R.

Immunobiology. 2015 Jan;220(1):20-5.

PMID:
25446398
18.

Increased production of nitric oxide correlates with tumor growth in Algerian patients with nasopharyngeal carcinoma.

Bourouba M, Boukercha A, Zergoun AA, Zebboudj A, Elhadjan M, Djenaoui D, Asselah F, Touil-Boukoffa C.

Biomarkers. 2012 Nov;17(7):618-24. doi: 10.3109/1354750X.2012.706643. Epub 2012 Jul 21.

PMID:
22817561
19.
20.

AIMP2-DX2 Promotes the Proliferation, Migration, and Invasion of Nasopharyngeal Carcinoma Cells.

Cao Q, Zhang J, Zhang T.

Biomed Res Int. 2018 Apr 16;2018:9253036. doi: 10.1155/2018/9253036. eCollection 2018.

Supplemental Content

Support Center